KATIE LUIGS: Open Payments
NPI 1487080529 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 29 payments from 14 companies in 2025. Trend: 2023 $1,392 · 2024 $634 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $177 |
| Madrigal Pharmaceuticals | 2 | $69 |
| GENZYME CORPORATION | 2 | $49 |
| Janssen Biotech, Inc. | 2 | $45 |
| Braintree Laboratories, Inc. | 2 | $43 |
| Organon LLC | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| QOL Medical, LLC | 1 | $25 |
Products named: RINVOQ, DUPIXENT, REZDIFFRA, TREMFYA, SUFLAVE, HADLIMA, ENTYVIO, VOQUEZNA.
Industry payments across IN — which companies pay providers there.
